Newbridge Financial Services Group, Inc. 180 Life Sciences Corp. Transaction History

Newbridge Financial Services Group, Inc.

  • $275 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022
SELL
$0.81 - $2.53 $2,430 - $7,589
-3,000 Reduced 85.71%
500 $0
Q4 2021

Jan 19, 2022
BUY
$3.27 - $6.38 $1,635 - $3,190
500 Added 16.67%
3,500 $14,000
Q2 2021

Sep 07, 2021
BUY
$6.7 - $11.98 $20,100 - $35,940
3,000 New
3,000 $30,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email